Recent from talks
Ajay Piramal
Knowledge base stats:
Talk channels stats:
Members stats:
Ajay Piramal
Ajay Gopikisan Piramal (born 3 August 1955) is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. As of September 2025, his net worth is estimated at US$3.3 billion.
Ajay Piramal was born to Gopikisan Piramal and Lalita Piramal in Rajasthan, India on 3 August 1955. In 1977, at age 22, Piramal started out in his family's textile business, founded in 1934 by his grandfather Piramal Chatrabhuj. His father, Gopikisan Piramal, died in 1979, and after five years he lost an older brother to cancer, prompting him to take over the business.
Piramal holds a bachelor's degree in Science from the Jai Hind College and Basantsingh Institute of Science, University of Mumbai (then Bombay), a master's degree in management studies from Jamnalal Bajaj Institute of Management Studies, University of Mumbai, and in 1992 attended the six-week Advanced Management Programme at Harvard Business School. Piramal has received an honorary doctorate by Amity University, India and Honorary Doctor of Science from IIT Indore.
In 1988, Piramal bought Nicholas Laboratories, an Australian multinational corporation. The company is now ranked fifth among pharma companies in India, having made a string of overseas acquisitions like the Indian subsidiaries of Roche, Boehringer Mannheim, Rhone Poulenc, ICI and Hoechst Research Centre. India's first major shopping mall, Crossroads, was developed from three redundant Piramal factory buildings in Mumbai.
He led Piramal Enterprises Ltd invested in Vodafone India by buying 11% in two tranches. The first 5.5%, was bought in 2011 for Rs 2,856 crore and the second, the next year for Rs 3,007 crore to buy a 5.5% stake in Vodafone India for INR 30.07 billion ($618 million), taking the total stake to 11%. In April 2014, Piramal Enterprises Ltd. sold its 11% stake for INR 8,900 crore, at a 51.78% premium to the price the company had paid in 2011–12.
After selling his stake in Vodafone India, Piramal paid INR 2,014 crore to buy a 20% stake in Shriram Capital Ltd., an arm of the Chennai-based Shriram Group. The purchase was made in addition to INR 1,636 crore investment in Shriram Transport Finance Co. Ltd. for a 9.9% stake. Piramal also serves as the Chairman of Shriram Group.
Piramal announced in 2019 he planned to resign as chairman of Shriram Capital Ltd. He was named chairman five years earlier.
Piramal finances the Piramal Foundation. The foundation is quoted as taking about 10–15% of his time. The Piramal Foundation is the philanthropic arm of the Piramal Group.
Hub AI
Ajay Piramal AI simulator
(@Ajay Piramal_simulator)
Ajay Piramal
Ajay Gopikisan Piramal (born 3 August 1955) is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. As of September 2025, his net worth is estimated at US$3.3 billion.
Ajay Piramal was born to Gopikisan Piramal and Lalita Piramal in Rajasthan, India on 3 August 1955. In 1977, at age 22, Piramal started out in his family's textile business, founded in 1934 by his grandfather Piramal Chatrabhuj. His father, Gopikisan Piramal, died in 1979, and after five years he lost an older brother to cancer, prompting him to take over the business.
Piramal holds a bachelor's degree in Science from the Jai Hind College and Basantsingh Institute of Science, University of Mumbai (then Bombay), a master's degree in management studies from Jamnalal Bajaj Institute of Management Studies, University of Mumbai, and in 1992 attended the six-week Advanced Management Programme at Harvard Business School. Piramal has received an honorary doctorate by Amity University, India and Honorary Doctor of Science from IIT Indore.
In 1988, Piramal bought Nicholas Laboratories, an Australian multinational corporation. The company is now ranked fifth among pharma companies in India, having made a string of overseas acquisitions like the Indian subsidiaries of Roche, Boehringer Mannheim, Rhone Poulenc, ICI and Hoechst Research Centre. India's first major shopping mall, Crossroads, was developed from three redundant Piramal factory buildings in Mumbai.
He led Piramal Enterprises Ltd invested in Vodafone India by buying 11% in two tranches. The first 5.5%, was bought in 2011 for Rs 2,856 crore and the second, the next year for Rs 3,007 crore to buy a 5.5% stake in Vodafone India for INR 30.07 billion ($618 million), taking the total stake to 11%. In April 2014, Piramal Enterprises Ltd. sold its 11% stake for INR 8,900 crore, at a 51.78% premium to the price the company had paid in 2011–12.
After selling his stake in Vodafone India, Piramal paid INR 2,014 crore to buy a 20% stake in Shriram Capital Ltd., an arm of the Chennai-based Shriram Group. The purchase was made in addition to INR 1,636 crore investment in Shriram Transport Finance Co. Ltd. for a 9.9% stake. Piramal also serves as the Chairman of Shriram Group.
Piramal announced in 2019 he planned to resign as chairman of Shriram Capital Ltd. He was named chairman five years earlier.
Piramal finances the Piramal Foundation. The foundation is quoted as taking about 10–15% of his time. The Piramal Foundation is the philanthropic arm of the Piramal Group.
Recent media